Cellular Intelligence, backed by the Chan Zuckerberg Initiative, is building an AI model to predict how cells respond to signals over time, supported by a capsule platform that enables exponential experimentation. Here’s...
The randomized, double-blind study will enroll about 150 patients to receive intravenous ALT001 at one of two doses or placebo, with functional change assessed at 24 weeks.
The UMC Utrecht-sponsored, randomized placebo-controlled study plans to enroll 162 infants with MRI-confirmed hypoxic-ischemic brain injury and assess motor development at 24 months.
Researchers used whole-genome sequencing and a machine-learning RNA assay to assess dopamine neuron precursors made from patients’ skin cells for identity and consistency.
A small trial tested whether repeated donor cord blood cell infusions could safely influence social symptoms in children with autism and blood signs of immune dysregulation.
The approval was based on a trial comparing 17 treated children with 27 untreated peers, with follow-up extending to nearly eight years and shipments expected within 30 to 60 days.
Backed by $6.4M in grants, the team will create and validate more than 20 patient-derived stem cell lines, then share the cells, protocols and data publicly.
The designation was based on early U.S. trial data in spinal cord injury patients, where this non-replicating HSV-1 gene therapy is being tested as a single-course treatment aimed at reducing bladder overactivity...
Up to 40 patients with relapsed or refractory multiple myeloma may enroll to test an approach designed to generate engineered T cells inside the body.
The multicenter study will begin with 6 to 24 participants to select a dose, followed by about 95 participants divided into two disease-pattern cohorts.